RxDoctor Payments Data

Morgan McEwin, NP

Acute Care · Columbia, MONPI 1417423286

Payments from drug & device makers

What this record shows

Atricure, Inc. accounts for 82.4% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $2,886, 6.1 times the $472 reported in 2021. Among acute care clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,427in general payments, 2019–2025

Across 36 payments — averaging $95.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$3K
  • Lantheus Medical Imaging, Inc.$226
  • Edwards Lifesciences$101
  • Boston Scientific$55
  • Alnylam Pharmaceuticals Inc.$53
  • La Jolla Pharmaceutical Company$43
  • plus $126 from 5 others

What the payments were for

  • Travel & lodging$1,77552%
  • Food & beverage$1,65248%

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,427 in reported general payments places this provider in the 90th percentile of 272 acute care providers in Missouri.

See all acute care providers in Missouri

Medicare billing

Part B allowed, 2024
$4,319
Medicare patients
26
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban13$8,399
EliquisApixaban12$7,131
ClopidogrelClopidogrel Bisulfate62$448
Metoprolol Tartrate86$232
Amiodarone Hcl25$221
Potassium Chloride63$205
Atorvastatin Calcium48$200
Oxycodone Hcl56$195
Tramadol Hcl72$160
Spironolactone21$95
Furosemide58$79

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$16$8,39913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 272 acute care providers in Missouri.

Other acute care in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →